TY - JOUR
T1 - The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
AU - Nielsen, Susan
AU - Herlin, Troels
AU - Estmann Christensen, Anne
AU - Zak, Marek
AU - Myrup, Charlotte
AU - Glerup, Mia
AU - Consolaro, Alessandro
AU - Bovis, Francesca
AU - Ruperto, Nicolino
AU - Paediatric Rheumatology International Trials Organisation (PRINTO)
PY - 2018
Y1 - 2018
N2 - The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient-reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Danish language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability and construct validity (convergent and discriminant validity). A total of 303 JIA patients (7.9% systemic, 35% oligoarticular, 22.1% RF negative polyarthritis, 35% other categories) and 99 healthy children, were enrolled in three centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Danish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.
AB - The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient-reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Danish language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability and construct validity (convergent and discriminant validity). A total of 303 JIA patients (7.9% systemic, 35% oligoarticular, 22.1% RF negative polyarthritis, 35% other categories) and 99 healthy children, were enrolled in three centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Danish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.
KW - Adolescent
KW - Age of Onset
KW - Arthritis, Juvenile/diagnosis
KW - Case-Control Studies
KW - Child
KW - Child, Preschool
KW - Cultural Characteristics
KW - Denmark
KW - Disability Evaluation
KW - Female
KW - Health Status
KW - Humans
KW - Male
KW - Parents/psychology
KW - Patient Reported Outcome Measures
KW - Patients/psychology
KW - Predictive Value of Tests
KW - Prognosis
KW - Psychometrics
KW - Quality of Life
KW - Reproducibility of Results
KW - Rheumatology/methods
KW - Translating
U2 - 10.1007/s00296-018-3946-z
DO - 10.1007/s00296-018-3946-z
M3 - Journal article
C2 - 29637339
VL - 38
SP - 131
EP - 138
JO - Rheumatology International
JF - Rheumatology International
SN - 0172-8172
IS - Suppl 1
ER -